Israeli pharma giant Teva reports shrinking profits amid U.S. opioid litigation - U.S. News - Haaretz.com
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceutical Is in Recovery - WSJ
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Opioid firm Teva agrees $85m settlement days before Oklahoma case goes to court | US News | Sky News
Teva Pharmaceuticals Reviews | Glassdoor
Teva Faces Rocky Path to Recovery After Debt | Fortune
Here's Why Teva Pharma Stock Is Soaring Today
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
TEVA: Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceutical Stock Could Double | Barron's
